Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: All the BPH patients having prostate specific antigen levels less than 4 ng per ml and are benign as diagnosed by Digital Rectal Examination
Exclusion criteria
Exclusion criteria: 1. Patients with chronic illnesses such as diabetes and hypertension, metabolic syndrome, any other disease due to malnutrition. 2. Conditions known to interfere with electrolyte measurement such as dehydration, patients on medications such as diuretics, men on dietary supplements will be excluded from the study. 3. The patients with renal and liver dysfunction. 4. Patients taking Calcium Channel blockers , patients with coronary artery disease and colorectal cancer will also be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the prevalence of calcium and magnesium levels in individuals diagnosed with Benign Prostatic HyperplasiaTimepoint: At the time of presentation in the Department of Urology | — |
Secondary
| Measure | Time frame |
|---|---|
| To categorize BPH patients into mild, moderate, & severe groups based on the International Prostate Symptom Score & analyze the category wise correlations between calcium & magnesium imbalanceTimepoint: At the time of presentation in the Department of Urology | — |
Countries
India
Contacts
Public ContactMohammad Shazib Faridi
Dr Baba Saheb Ambedkar Medical College & Hospital
Outcome results
None listed